What is it about?
This article describes the views and expectations of all stakeholders about marketing authorization for new drugs
Featured Image
Read the Original
This page is a summary of: Marketing Authorization Procedures for Advanced Cancer Drugs, Medical Decision Making, February 2017, SAGE Publications,
DOI: 10.1177/0272989x17691953.
You can read the full text:
Contributors
The following have contributed to this page